🔗 Share this article

This year's prestigious award in medical science has been awarded for revolutionary discoveries that clarify how the body's defense network attacks harmful infections while sparing the healthy tissues.

Three renowned scientists—from Japan Shimon Sakaguchi and US scientists Dr. Brunkow and Fred Ramsdell—received this honor.

The research uncovered specialized "security guards" within the immune system that eliminate malfunctioning defense cells that could attacking the body.

The findings are now paving the way for new treatments for immune disorders and malignancies.

The laureates will divide a monetary award worth 11 million Swedish kronor.

Crucial Findings

"Their research has been essential for comprehending how the immune system operates and the reason we don't all suffer from severe self-attack conditions," commented the head of the award panel.

This trio's studies address a core question: How does the defense system defend us from numerous infections while leaving our own tissues unharmed?

The immune system employs immune cells that search for indicators of disease, even pathogens and bacteria it has never encountered.

These cells employ sensors—known as receptors—that are generated by chance in countless combinations.

That gives the defense network the capacity to combat a broad range of threats, but the unpredictability of the mechanism inevitably creates immune cells that may target the host.

Protectors of the Body

Researchers earlier understood that some of these harmful defense cells were eliminated in the immune organ—the site where white blood cells mature.

The latest Nobel Prize recognizes the identification of T-reg cells—known as the immune system's "peacekeepers"—which travel through the system to neutralize other defenders that attack the healthy cells.

It is known that this process malfunctions in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

A prize committee stated, "These findings have established a new field of investigation and accelerated the development of new treatments, for example for tumors and immune disorders."

In cancer, regulatory T-cells block the system from attacking the growth, so studies are focused on reducing their quantity.

In self-attack disorders, trials are testing increasing T-reg cells so the organism is no longer being harmed. A comparable method could also be effective in minimizing the chances of organ transplant failure.

Pioneering Studies

Professor Sakaguchi, from a Japanese institution, performed tests on rodents that had their immune gland extracted, causing autoimmune disease.

He demonstrated that injecting immune cells from other animals could stop the illness—suggesting there was a system for preventing immune cells from harming the host.

Dr. Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in a California city, were investigating an genetic autoimmune disease in mice and people that led to the discovery of a genetic factor critical for the way T-regs operate.

"Their groundbreaking work has uncovered how the body's defenses is controlled by regulatory T cells, preventing it from mistakenly targeting the healthy cells," commented a prominent physiology specialist.

"The work is a striking illustration of how fundamental biological research can have far-reaching implications for public health."